As interest in regenerative medicine continues to grow, patients are increasingly exploring stem cell therapy for conditions such as knee osteoarthritis, tendon injuries, and neurological disorders. However, one of the most important — and often overlooked — questions is not whether stem cell therapy works, but how to choose the right clinic.

Not all stem cell clinics operate under the same medical standards. In practice, there is a significant difference between clinics that follow a clinically guided, physician-led approach and those that are primarily structured around marketing-driven service models.

Understanding this distinction is essential for patient safety, realistic expectations, and treatment outcomes.

The Core Difference: Medical Decision vs Product Offering

At a fundamental level, the difference lies in how treatment decisions are made.

A medical-grade stem cell clinic typically operates within a structured clinical framework, where treatment decisions are based on patient-specific factors such as medical history, imaging, and overall condition. In this setting, stem cell therapy is considered as one of several possible treatment options, rather than a default solution.

Across the broader regenerative medicine landscape, some clinics may also offer stem cell therapy as part of a wider wellness or anti-aging program. While these services can play a role in certain contexts, they are often structured differently from indication-based medical care.

For patients, the key distinction lies in how treatment decisions are made — whether stem cell therapy is recommended based on clinical evaluation, or offered as part of a generalized program.

1. Physician Involvement and Clinical Oversight

One of the most important indicators of a medical-grade clinic is active physician involvement, particularly from specialists relevant to the condition being treated. For example:

• Orthopedic surgeons for joint and musculoskeletal conditions
• Neurosurgeons or neurologists for neurological cases

In these settings, stem cell therapy is considered within the broader context of available treatments — including physiotherapy, medication, PRP, or surgery. By contrast, in marketing-driven environments:

• Treatment recommendations may be standardized
• Physician involvement may be limited or procedural
• The same protocol may be applied across multiple conditions

A key question patients should ask is:

“Is my case being evaluated by a specialist, or am I being offered a pre-set package?”

2. Indication-Based Use vs Generalized Application

Medical-grade clinics use stem cell therapy selectively, based on clinical indication. For example, in knee osteoarthritis:

• Patients with mild to moderate degeneration may benefit from regenerative approaches
• Advanced cases with severe structural damage may still require surgical options

Similarly, for tendon injuries:

• Partial tears may respond to regenerative support
• Complete ruptures often require surgical repair

In contrast, marketing-driven clinics may:

• Promote stem cells as suitable for nearly all patients
• Emphasize benefits without clearly defining limitations
• Avoid discussing cases where treatment may not be effective

A clinically responsible approach includes both indications and contraindications.

3. Transparency Around Limitations and Outcomes

In evidence-based medicine, no treatment is universally effective. This applies to stem cell therapy as well.

Medical-grade clinics will typically:

• Discuss variability in outcomes
• Clarify that results are not guaranteed
• Explain that stem cells work through biological signaling (e.g. anti-inflammatory and regenerative support), not direct tissue replacement

They may also explain realistic timelines:

• Weeks to months for noticeable changes
• Longer for chronic or complex conditions

In contrast, marketing-driven clinics may:

• Emphasize rapid or dramatic results
• Use generalized success claims
• Avoid discussing non-responders or partial outcomes

Patients should be cautious of any clinic that presents stem cell therapy as a predictable or universal solution.

4. Laboratory Standards and Cell Quality

Another critical factor is the source and quality of stem cells.

Medical-grade clinics typically use:

• Cells from GMP-certified laboratories
• Documented quality parameters (e.g. viability, sterility, passage number)
• Traceable sourcing and batch documentation

They may provide:

• Certificates of analysis (COA)
• Screening for contamination and safety

In contrast, less regulated settings may:

• Provide limited information about cell sourcing
• Focus more on quantity than quality
• Lack transparency in laboratory processes

While patients may not need to understand all technical details, they should expect clear documentation and traceability.

5. Treatment Framing: Therapy vs Product

The way stem cell therapy is presented also reflects the clinic’s underlying approach. In medical settings:

• Stem cell therapy is framed as a treatment option, not a product
• It is discussed alongside other modalities
• Decisions are individualized

In marketing-driven environments:

• Therapy may be packaged into predefined programs
• Pricing and packages may be emphasized early in the conversation
• Treatment may be positioned similarly to elective services

This distinction affects not only perception, but also clinical appropriateness.

6. Scope of Services and Clinical Focus

Many modern clinics offer a range of services, including regenerative medicine, IV therapy, and aesthetic procedures. This reflects the evolving landscape of patient demand, where both clinical treatment and wellness-oriented care may coexist within the same center.

However, the key factor is not the number of services offered, but how they are structured and clinically guided.

In more clinically focused settings, regenerative medicine is typically anchored within defined medical domains — such as orthopedics or neurology — where treatment decisions are made based on specific conditions and indications.

Additional services, such as IV therapy or aesthetic procedures, may be offered as complementary programs, but are usually positioned separately from core medical treatments.

For patients, this distinction is important. A center that clearly differentiates between indication-based clinical care and elective or supportive programs tends to provide more structured decision-making and clearer expectations.

7. Patient Selection and Screening

Perhaps the most important feature of a medical-grade clinic is selectivity.

Not every patient is a suitable candidate for stem cell therapy.

A responsible clinical process may include:

• Review of imaging (e.g. MRI, X-ray)
• Medical history assessment
• Blood tests or screening protocols
• Discussion of alternative treatments

In some cases, patients may be advised:

• To delay treatment
• To pursue physiotherapy or medication first
• That stem cell therapy is not appropriate

This level of selectivity is often absent in marketing-driven models, where the emphasis is on treatment uptake rather than clinical indication.

How Patients Can Make an Informed Decision

When evaluating a stem cell clinic, patients may consider asking:

• Is my case reviewed by a relevant medical specialist?
• Are both indications and limitations clearly explained?
• Is the source and quality of the cells documented?
• Are alternative treatments discussed?
• Is the recommendation personalized or standardized?

These questions can help distinguish between a clinic that prioritizes clinical appropriateness and one that prioritizes service delivery.

Stem cell therapy represents a promising area of regenerative medicine, but outcomes depend heavily on how and when it is used.

The difference between a medical-grade clinic and a marketing-driven model is not always visible at first glance, but it becomes clear through:

• Clinical decision-making processes
• Physician involvement
• Transparency
• Patient selection

For patients, choosing the right clinic is not simply about accessing treatment — it is about ensuring that the treatment is appropriate, safe, and guided by medical reasoning.

About EDNA Wellness

EDNA Wellness is a surgeon-led regenerative medicine center in Bangkok, specializing in orthopedic and neurological conditions using Umbilical Cord–Derived Mesenchymal Stem Cells (UC-MSCs).

All cases are reviewed by orthopedic surgeons and neurosurgeons, with a focus on clinical indication, patient safety, and realistic treatment expectations. Stem cell therapy is recommended selectively, and alternative treatments are considered when more appropriate.

For more information or to book a consultation:

LINE: @ednawellness

WhatsApp: +66 (0) 64 505 5599

www.ednawellness.com

References

• Pittenger MF, et al. Mesenchymal stem cell perspective: cell biology to clinical progress. https://www.nature.com/articles/s41536-019-0083-6
• Freitag J, et al. Mesenchymal stem cell therapy in the treatment of osteoarthritis: reparative pathways, safety and efficacy – a review. https://pubmed.ncbi.nlm.nih.gov/27229856/